Fund shareholders of Apogee Therapeutics Inc
ISIN US03770N1019 · United States
- Fund shareholders
- 291
- Of which ETFs
- 51 240 other funds
- Value held
- 2.6B $ 84K € · 16.9M SEK
- Share of capital
- 42.1 % of 75.3M shares on Jun 30, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| T. Rowe Price Capital Appreciation Fund T. ROWE PRICE CAPITAL APPRECIATION FUND, INC. | 5,295,932 | 445.8M $ | 0.67 % | 7.03 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,840,364 | 154.9M $ | 0.01 % | 2.44 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 1,698,393 | 118.9M $ | 0.14 % | 2.25 % | as of Feb 28, 2026 ↗ |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 1,490,737 | 123.6M $ | 0.34 % | 1.98 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 1,134,394 | 95.5M $ | 1.28 % | 1.51 % | as of Mar 31, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Fund JNL Series Trust | 1,125,673 | 94.7M $ | 0.69 % | 1.49 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 ETF iShares Trust | 1,054,983 | 88.8M $ | 0.12 % | 1.40 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Mid-Cap Growth Fund, Inc. T. ROWE PRICE MID-CAP GROWTH FUND, INC. | 802,067 | 67.5M $ | 0.30 % | 1.06 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Capital Appreciation Equity ETF T. Rowe Price Exchange-Traded Funds, Inc. | 634,849 | 53.4M $ | 0.86 % | 0.84 % | as of Mar 31, 2026 ↗ |
| Fidelity Blue Chip Growth Fund Fidelity Securities Fund | 621,363 | 51.5M $ | 0.05 % | 0.82 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 598,603 | 50.4M $ | 0.06 % | 0.79 % | as of Mar 31, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 557,423 | 46.9M $ | 2.96 % | 0.74 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 555,098 | 46.7M $ | 0.43 % | 0.74 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXPLORER FUND VANGUARD EXPLORER FUND | 530,576 | 44M $ | 0.20 % | 0.70 % | as of Apr 30, 2026 ↗ |
| VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO Voya Investors Trust | 523,799 | 44.1M $ | 0.67 % | 0.70 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 511,830 | 35.8M $ | 0.15 % | 0.68 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 493,826 | 34.6M $ | 0.16 % | 0.66 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 452,639 | 37.5M $ | 1.97 % | 0.60 % | as of Apr 30, 2026 ↗ |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 439,935 | 36.5M $ | 0.11 % | 0.58 % | as of Apr 30, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 392,757 | 27.5M $ | 0.51 % | 0.52 % | as of Feb 28, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND | 379,608 | 32M $ | 0.61 % | 0.50 % | as of Mar 31, 2026 ↗ |
| Penn Series Flexibly Managed Fund Penn Series Funds Inc | 375,718 | 31.6M $ | 0.68 % | 0.50 % | as of Mar 31, 2026 ↗ |
| Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust | 362,287 | 30.5M $ | 0.33 % | 0.48 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 Growth ETF iShares Trust | 359,030 | 30.2M $ | 0.25 % | 0.48 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 353,520 | 29.8M $ | 0.37 % | 0.47 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Growth Fund JPMorgan Trust II | 351,529 | 29.6M $ | 1.36 % | 0.47 % | as of Mar 31, 2026 ↗ |
| SMALLCAP World Fund Inc SMALLCAP World Fund Inc | 348,674 | 29.3M $ | 0.04 % | 0.46 % | as of Mar 31, 2026 ↗ |
| Fidelity Contrafund Fidelity Contrafund | 328,062 | 27.6M $ | 0.02 % | 0.44 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 299,965 | 24.9M $ | 0.30 % | 0.40 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 264,646 | 22.3M $ | 0.27 % | 0.35 % | as of Mar 31, 2026 ↗ |
| AB Small Cap Growth Portfolio AB CAP FUND, INC. | 253,333 | 21M $ | 0.72 % | 0.34 % | as of Apr 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 253,231 | 17.7M $ | 0.04 % | 0.34 % | as of Feb 28, 2026 ↗ |
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 240,387 | 16.8M $ | 1.15 % | 0.32 % | as of Feb 27, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 235,622 | 16.5M $ | 0.08 % | 0.31 % | as of Feb 28, 2026 ↗ |
| AB DISCOVERY GROWTH FUND, INC. AB DISCOVERY GROWTH FUND, INC. | 216,053 | 17.9M $ | 0.67 % | 0.29 % | as of Apr 30, 2026 ↗ |
| Loomis Sayles Small Cap Growth Fund LOOMIS SAYLES FUNDS II | 203,012 | 17.1M $ | 0.89 % | 0.27 % | as of Mar 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 202,950 | 14.2M $ | 0.22 % | 0.27 % | as of Feb 27, 2026 ↗ |
| Driehaus Small Cap Growth Fund Driehaus Mutual Funds | 198,229 | 16.7M $ | 1.45 % | 0.26 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 190,783 | 13.4M $ | 0.09 % | 0.25 % | as of Feb 28, 2026 ↗ |
| Federated Hermes Kaufmann Fund Federated Hermes Equity Funds | 143,485 | 11.9M $ | 0.26 % | 0.19 % | as of Apr 30, 2026 ↗ |
| JNL/T. Rowe Price Mid-Cap Growth Fund JNL Series Trust | 143,282 | 12.1M $ | 0.30 % | 0.19 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Growth K6 Fund Fidelity Securities Fund | 126,676 | 10.5M $ | 0.24 % | 0.17 % | as of Apr 30, 2026 ↗ |
| Fidelity Blue Chip Growth K6 Fund Fidelity Securities Fund | 124,951 | 10.4M $ | 0.05 % | 0.17 % | as of Apr 30, 2026 ↗ |
| JPMorgan Small Cap Blend Fund JPMorgan Trust I | 113,530 | 9.6M $ | 0.67 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Blue Chip Growth Fund Fidelity Securities Fund | 113,014 | 9.4M $ | 0.05 % | 0.15 % | as of Apr 30, 2026 ↗ |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 97,424 | 8.1M $ | 0.11 % | 0.13 % | as of Apr 30, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 95,791 | 6.7M $ | 0.03 % | 0.13 % | as of Feb 28, 2026 ↗ |
| EQ/AB Small Cap Growth Portfolio EQ Advisors Trust | 94,739 | 8M $ | 0.42 % | 0.13 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 92,043 | 6.4M $ | 0.01 % | 0.12 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Institutional Mid-Cap Equity Growth Fund T. Rowe Price Equity Funds, Inc. | 90,543 | 7.6M $ | 0.28 % | 0.12 % | as of Mar 31, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Equity Fund JNL Series Trust | 89,526 | 7.5M $ | 0.83 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 88,541 | 7.3M $ | 0.26 % | 0.12 % | as of Apr 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 82,737 | 6.9M $ | 0.66 % | 0.11 % | as of Apr 30, 2026 ↗ |
| JNL Multi-Manager Small Cap Growth Fund JNL Series Trust | 81,190 | 6.8M $ | 0.34 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 79,691 | 5.6M $ | 0.09 % | 0.11 % | as of Feb 28, 2026 ↗ |
| Victory Science & Technology Fund Victory Portfolios III | 75,851 | 6.3M $ | 0.45 % | 0.10 % | as of Apr 30, 2026 ↗ |
| MassMutual Mid Cap Growth Fund MASSMUTUAL SELECT FUNDS | 75,317 | 6.3M $ | 0.23 % | 0.10 % | as of Mar 31, 2026 ↗ |
| SmallCap Growth Fund I Principal Funds, Inc | 74,739 | 6.2M $ | 0.26 % | 0.10 % | as of Apr 30, 2026 ↗ |
| Federated Hermes MDT Small Cap Core Fund Federated Hermes MDT Series | 73,107 | 6.1M $ | 0.32 % | 0.10 % | as of Apr 30, 2026 ↗ |
| Master Small Cap Index Series Quantitative Master Series LLC | 72,177 | 6.1M $ | 0.13 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 71,986 | 5M $ | 0.01 % | 0.10 % | as of Feb 28, 2026 ↗ |
| AZL T Rowe Price Capital Appreciation Fund Allianz Variable Insurance Products Trust | 71,260 | 6M $ | 0.68 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Fidelity Contrafund K6 Fidelity Contrafund | 70,378 | 5.9M $ | 0.02 % | 0.09 % | as of Mar 31, 2026 ↗ |
| THE HARTFORD SMALL COMPANY FUND HARTFORD MUTUAL FUNDS, INC | 69,056 | 5.7M $ | 0.86 % | 0.09 % | as of Apr 30, 2026 ↗ |
| Franklin Small Cap Growth Fund Franklin Strategic Series | 68,595 | 5.7M $ | 0.23 % | 0.09 % | as of Apr 30, 2026 ↗ |
| Empower T. Rowe Price Mid Cap Growth Fund EMPOWER FUNDS, INC. | 67,396 | 5.7M $ | 0.30 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 65,006 | 5.4M $ | 1.04 % | 0.09 % | as of Apr 30, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 63,945 | 5.4M $ | 0.01 % | 0.08 % | as of Mar 31, 2026 ↗ |
| VIP Contrafund Portfolio Variable Insurance Products Fund II | 63,800 | 5.4M $ | 0.02 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Column Small Cap Select Fund Trust for Professional Managers | 57,950 | 4.1M $ | 0.23 % | 0.08 % | as of Feb 28, 2026 ↗ |
| Driehaus Micro Cap Growth Fund Driehaus Mutual Funds | 56,510 | 4.8M $ | 1.04 % | 0.08 % | as of Mar 31, 2026 ↗ |
| AST Small-Cap Equity Portfolio Advanced Series Trust | 55,555 | 4.7M $ | 0.25 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor New Insights Fund Fidelity Contrafund | 55,400 | 4.7M $ | 0.02 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 55,316 | 4.6M $ | 0.16 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Multi-Manager Small Cap Equity Strategies Fund COLUMBIA FUNDS SERIES TRUST I | 54,958 | 3.8M $ | 0.31 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Small Cap Core Portfolio Bernstein Fund Inc | 53,133 | 4.5M $ | 0.63 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Nuveen Small Cap Blend Index Fund TIAA-CREF Funds | 52,055 | 4.3M $ | 0.11 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Capital Appreciation Value Fund John Hancock Funds II | 51,992 | 3.6M $ | 0.33 % | 0.07 % | as of Feb 28, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 48,872 | 3.4M $ | 2.48 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Federated Hermes MDT Small Cap Growth Fund Federated Hermes MDT Series | 46,002 | 3.8M $ | 0.51 % | 0.06 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | 45,469 | 3.8M $ | 0.04 % | 0.06 % | as of Mar 31, 2026 ↗ |
| HARTFORD SMALL COMPANY HLS FUND HARTFORD SERIES FUND INC | 44,522 | 3.7M $ | 0.96 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Small Cap Growth Stock Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 43,904 | 3.7M $ | 0.50 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Victory RS Small Cap Growth Fund Victory Portfolios | 43,710 | 3.7M $ | 1.11 % | 0.06 % | as of Mar 31, 2026 ↗ |
| EQ/2000 Managed Volatility Portfolio EQ Advisors Trust | 42,603 | 3.6M $ | 0.11 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Small-Cap Growth Portfolio PACIFIC SELECT FUND | 40,937 | 3.4M $ | 0.78 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Capital Appreciation Value Trust John Hancock Variable Insurance Trust | 38,448 | 3.2M $ | 0.70 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Small Cap Growth Fund Goldman Sachs Trust | 38,036 | 2.7M $ | 0.63 % | 0.05 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Mid Cap Growth Portfolio Brighthouse Funds Trust I | 37,174 | 3.1M $ | 0.30 % | 0.05 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 36,630 | 3.1M $ | 0.00 % | 0.05 % | as of Mar 31, 2026 ↗ |
| First Trust US Equity Opportunities ETF First Trust Exchange-Traded Fund | 36,475 | 3.1M $ | 0.26 % | 0.05 % | as of Mar 31, 2026 ↗ |
| THE HARTFORD HEALTHCARE FUND HARTFORD MUTUAL FUNDS, INC | 35,692 | 3M $ | 0.41 % | 0.05 % | as of Apr 30, 2026 ↗ |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 35,309 | 2.5M $ | 0.17 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 34,876 | 2.4M $ | 0.33 % | 0.05 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 34,862 | 2.9M $ | 0.44 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Growth Index Fund Fidelity Salem Street Trust | 33,815 | 2.8M $ | 0.25 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Eaton Vance Worldwide Health Sciences Fund Eaton Vance Growth Trust | 33,655 | 2.4M $ | 0.27 % | 0.04 % | as of Feb 28, 2026 ↗ |
| T.Rowe Price Small Cap Growth Portfolio Brighthouse Funds Trust II | 33,408 | 2.8M $ | 0.27 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Loomis Sayles Small Cap Growth Portfolio Brighthouse Funds Trust II | 32,743 | 2.8M $ | 0.87 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 32,625 | 2.7M $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 2.96 % | as of Mar 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 2.48 % | as of Feb 28, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 2.43 % | as of Mar 31, 2026 ↗ |
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 2.29 % | as of Dec 31, 2025 ↗ |
| AMG Frontier Small Cap Growth Fund AMG Funds I | 2.13 % | as of Apr 30, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 1.97 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Future Health Care Equity ETF Goldman Sachs ETF Trust | 1.62 % | as of Feb 28, 2026 ↗ |
| Driehaus Small Cap Growth Fund Driehaus Mutual Funds | 1.45 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Growth Fund JPMorgan Trust II | 1.36 % | as of Mar 31, 2026 ↗ |
| Global X Guru Index ETF GLOBAL X FUNDS | 1.29 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 289 | +35 | 31,675,127 | +37.0 % |
| 2026Q1 | 254 | +47 | 23,112,284 | +24.4 % |
| 2025Q4 | 207 | +1 | 18,584,543 | +5.4 % |
| 2025Q3 | 206 | -3 | 17,626,158 | -5.7 % |
| 2025Q2 | 209 | +7 | 18,689,532 | +5.2 % |
| 2025Q1 | 202 | +7 | 17,766,785 | +4.8 % |
| 2024Q4 | 195 | -2 | 16,950,625 | +5.2 % |
| 2024Q3 | 197 | +10 | 16,119,696 | +18.1 % |
| 2024Q2 | 187 | +66 | 13,649,363 | +113.0 % |
| 2024Q1 | 121 | +18 | 6,407,112 | +39.6 % |
| 2023Q4 | 103 | 4,589,067 |
Institutional managers
217 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 10,300,984 | 867K $ | as of Mar 31, 2026 |
| FMR LLC | 9,262,291 | 779.6M $ | as of Mar 31, 2026 |
| Venrock Adviser, LLC | 8,493,321 | 714.9M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 4,375,703 | 368.3M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 4,085,651 | 343.9M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 2,782,097 | 234.2M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 2,360,596 | 198.8M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,162,964 | 182.1M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 1,920,800 | 161.7M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 1,540,384 | 129.7M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 1,348,243 | 113.5M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 1,284,926 | 108.2M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,217,289 | 102.5M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,144,328 | 96.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,143,152 | 96.2K $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 1,110,470 | 87.4M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 1,100,000 | 92.6M $ | as of Mar 31, 2026 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 1,064,483 | 89.6M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 990,297 | 74.7M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 900,871 | 75.8M $ | as of Mar 31, 2026 |
| MERCER GLOBAL ADVISORS INC /ADV | 831,428 | 70M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 652,590 | 54.9M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 598,902 | 50.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 595,032 | 50.1M $ | as of Mar 31, 2026 |
| JENNISON ASSOCIATES LLC | 585,016 | 49.2M $ | as of Mar 31, 2026 |
Declared shareholders of Apogee Therapeutics Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 16.80 % | 10,291,220 | as of Mar 31, 2026 · SCHEDULE 13G |
| Fairmount Funds Management LLC and 3 others | 9.99 % | 6,808,789 | as of Jun 18, 2026 · SCHEDULE 13D |
Cite this page
Titelia. "Fund shareholders of Apogee Therapeutics Inc". https://titelia.com/en/stocks/apogee-therapeutics-inc-US03770N1019